Abbott Laboratories Profile Avatar - Palmy Investing

Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical De…
Medical - Devices
US, North Chicago [HQ]

Ratios

15 Sheets · Starting from 2023
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
57.06 58.30 60.00 62.08 54.05 54.47 57.13 56.73 54.96 58.45 58.53 56.65 56.97 56.15 55.18
Profit Margin
18.68 13.15 12.17 14.95 11.79 11.28 21.68 6.71 1.74 7.74 11.56 12.99 16.42 15.88 14.27
Operating Margin
20.27 17.31 14.81 20.28 12.03 12.84 14.05 15.27 6.30 11.94 14.21 15.48 19.56 19.16 16.15
EPS Growth
17.72 -19.62 0.67 25.58 -56.09 -9.04 98.68 -68.33 -71.58 400.00 53.33 21.74 57.54 -0.76 -16.24
Return on Assets (ROA)
10.96 7.78 7.84 8.87 6.00 5.53 10.72 2.66 0.63 3.53 5.43 6.20 9.40 9.31 7.82
Return on Equity (ROE)
25.14 20.66 19.35 22.32 10.23 10.61 20.85 6.82 1.54 7.76 11.86 13.71 19.75 18.90 14.83
Return on Invested Capital (ROIC)
12.67 11.93 13.13 16.31 7.83 6.05 7.77 5.63 0.46 5.92 8.20 9.19 13.24 12.83 10.39
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
31.39 31.82 25.57 30.45 15.28 19.01 21.82 41.78 36.62 29.13 27.83 27.08 25.28 23.80 20.38
Debt/Equity
72.00 84.50 63.07 76.63 26.07 36.44 42.44 107.15 90.38 64.10 60.78 59.94 53.09 48.29 38.66
Debt/EBITDA
119.37 224.99 146.79 115.07 89.40 120.45 106.70 121.36 373.93 263.48 225.77 168.74 85.65 73.24 84.81
Debt/Capitalization
41.86 45.80 38.68 43.38 20.68 26.71 29.79 51.73 47.47 39.06 37.80 37.47 34.68 32.56 27.88
Interest Debt per Share USD
10.89 12.59 10.15 13.31 4.30 5.25 6.15 15.17 16.46 11.56 11.01 11.36 10.98 10.32 8.94
Debt Growth
43.78 14.96 -18.52 32.84 -67.96 19.57 14.74 144.48 26.89 -29.93 -3.44 4.00 -3.27 -6.79 -10.40
Liquidity
Current Ratio
178.66 129.28 153.54 235.86 202.45 144.90 154.09 402.04 226.07 162.36 144.22 171.67 184.96 162.85 163.79
Quick Ratio
126.24 73.20 101.94 171.59 127.11 76.40 103.89 330.68 166.73 102.84 88.05 113.90 127.71 123.00 100.02
Cash Ratio
67.51 21.13 44.01 81.34 36.55 38.58 54.44 279.58 105.55 42.65 35.53 57.43 74.77 63.80 49.82
Operating Cash Flow Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Turnover
Inventory Turnover
404.58 459.90 473.20 398.70 372.82 348.77 336.55 370.75 342.60 334.72 306.56 299.34 359.45 310.09 273.59
Receivables Turnover
470.27 489.52 505.61 523.77 548.12 564.61 596.99 642.03 521.81 590.08 588.09 539.57 664.02 491.53 610.95
Payables Turnover
1,031.52 954.90 902.96 841.41 978.56 866.35 809.16 766.04 513.61 427.09 406.86 380.21 420.53 415.50 418.51
Asset Turnover
58.69 59.14 64.45 59.31 50.86 49.05 49.47 39.59 35.92 45.52 47.00 47.70 57.28 58.64 54.78
Coverage
Interest Coverage
1,632.46 1,100.64 1,084.99 1,576.02 2,921.11 3,560.27 4,943.10 959.34 221.28 506.24 786.81 1,071.40 1,719.39 2,229.87 1,016.95
Asset Coverage
200 100 200 200 400 300 300 100 100 200 200 200 200 200 300
Cash Flow Coverage (CFGR)
44.21 46.18 58.19 45.49 50.66 46.85 32.95 14.56 19.95 32.20 32.48 40.21 55.42 54.08 48.65
EBITDA Coverage
1,600 1,200 1,100 1,600 3,800 4,300 6,400 800 600 800 1,100 1,500 2,100 2,800 1,600
Dividend Coverage
-200 -100 -100 -100 -200 -100 -300 - - - - -100 -100 -100 -200 -200 -100
Time Interest Earned (TIE)
100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
Market Prospects
Dividend Yield
6.04 7.53 6.95 6.44 1.49 1.98 2.18 2.72 1.86 1.55 1.48 1.32 1.28 1.72 1.86
Earnings Yield
14.38 13.05 11.19 12.07 4.34 3.36 6.69 2.48 0.48 1.87 2.40 2.32 2.83 3.60 2.99
Price/Earnings (P/E)
695.21 766.44 893.47 828.66 2,303.52 2,972.49 1,495.31 4,040.92 20,861.09 5,362.50 4,165.13 4,318.70 3,532.93 2,776.03 3,346.53
Price/Book (P/B)
174.77 158.37 172.85 184.92 235.74 315.39 311.81 275.45 322.06 416.01 493.98 592.14 697.76 524.62 496.13
Price/Sales (P/S)
129.84 100.82 108.73 123.92 271.60 335.32 324.12 271.29 363.30 415.28 481.35 560.93 579.95 440.89 477.50
Price/Cash Flow (P/CF)
549.07 405.87 470.93 530.50 1,785.16 1,847.39 2,229.85 1,766.25 1,786.49 2,015.62 2,502.75 2,456.98 2,371.72 2,008.79 2,637.68